Results 131 to 140 of about 3,409,433 (269)

Automated Pharmacometric Model Development by Leveraging Low-Dimensional Neural ODEs and LASSO Regression. [PDF]

CPT Pharmacometrics Syst Pharmacol
Bräm DS, Steiert B, Steffens B, Pfister M, Koch G.   +4 more
europepmc   +1 more source

Nutrient/TOR signaling controls adipose mitochondrial transcription factor A (TFAM) to regulate organismal growth in Drosophila

FEBS Letters, EarlyView.
Animals must match their growth rate to available nutrients. We show that in Drosophila larvae, the nutrient‐sensing TOR kinase controls growth by regulating levels of TFAM, a key regulator of mitochondrial function, in the adipose tissue. When nutrients are abundant, high TOR activity suppresses TFAM, lowering mitochondrial bioenergetic activity and ...
Shrivani Sriskanthadevan‐Pirahas, Shahoon Khan, Abhishek Sharma, Byoungchun Lee, Savraj S. Grewal   +4 more
wiley   +1 more source

Psychometric functions for temporal discrimination: Duration or log duration? [PDF]

Behav Res Methods
García-Pérez MA, Alcalá-Quintana R.
europepmc   +1 more source

Peripheral lysosomes recruit PLEKHG3 to focal adhesions and restrain protrusion dynamics

FEBS Letters, EarlyView.
Proximity‐dependent labeling at the LAMTOR complex revealed the Rho GEF PLEKHG3 as a lysosome‐proximal protein directing the study toward the influence of lysosome positioning on actin dynamics and cell motility. We show that PLEKHG3 colocalizes with lysosomes at focal adhesion sites and observe that forced peripheral dispersion of lysosomes hinders ...
Rainer Ettelt, Ana‐Maria Sandru, Georg Vucak, Sebastian Didusch, Biljana Riemelmoser, Karin Ehrenreiter, Markus Hartl, Lukas A. Huber, Manuela Baccarini   +8 more
wiley   +1 more source

Beyond genomes: functional signatures reveal evolutionary patterns across the tree of life. [PDF]

Mol Biol Evol
Muñoz-Mérida A, Muñoz-Pajares AJ.
europepmc   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

FEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang, Ruslana Romaniuk, Hristo L. Svilenov   +2 more
wiley   +1 more source

Plasmonics of non-noble metals. [PDF]

RSC Adv
Horák M, Foltýn M, Bajo V, Dub P, Šikola T.   +4 more
europepmc   +1 more source

Lipschitz functions of continuous functions [PDF]

Pacific Journal of Mathematics, 1953
Marx, Imanuel, Piranian, George
openaire   +3 more sources

Epigenetic reprogramming of lineage switching in cancer

FEBS Letters, EarlyView.
Cancer cells rarely commit to a single identity. Epigenetic mechanisms and tumor microenvironment cues push epithelial cells toward flexible, hybrid states that can shift into mesenchymal, neuroendocrine, or stem‐like fates, driving metastasis, drug resistance, and tumor heterogeneity. Targeting the epigenetic regulators behind these transitions, using
Ezgi Boyvatlı, Burcu Akman, Ezgi Bağırsakçı, Nese Atabey, Serap Erkek‐Ozhan   +4 more
wiley   +1 more source

A Modified Multi-Strategy Dhole Optimization Algorithm and Its Engineering Applications. [PDF]

Biomimetics (Basel)
Zhang J, Liu Y, Jia C, Fu M, Yang Y, Liu J, Cheng Y.   +6 more
europepmc   +1 more source